COVID-19 Vaccine Acceptance among an Online Sample of Sexual and Gender Minority Men and Transgender Women.

TitleCOVID-19 Vaccine Acceptance among an Online Sample of Sexual and Gender Minority Men and Transgender Women.
Publication TypePublication
Year of Publication2021
Authorsda Silva DTeixeira, Biello K, Lin WY, Valente PK, Mayer KH, Hightow-Weidman L, Bauermeister JA
JournalVaccines (Basel)
Volume9
Issue3
Date Published2021 Mar 01
ISSN2076-393X
Abstract

<p>Sexual and gender minority (SGM) populations are particularly vulnerable to poor COVID-19 outcomes and are more likely to experience stigma and medical mistrust that may impact COVID-19 vaccine acceptance. This study examined the prevalence of COVID testing and diagnosis and assessed COVID-19 vaccine acceptance among a large sample of SGM. Participants were recruited as part of an online cross-sectional study focused on an HIV biomedical prevention technology willingness in the United States at increased risk for HIV sero-conversion. Multivariate linear analysis was conducted to examine COVID-19 vaccine acceptance. The study sample included 1350 predominately gay (61.6%), Black (57.9%), cis-gender (95.7%) males with a mean age of 32.9 years. Medical mistrust and social concern regarding COVID-19 vaccine stigma were significantly associated with decreased COVID-19 vaccine acceptance, and altruism was significantly associated with increased vaccine acceptance. Black participants were significantly less likely to accept a COVID-19 vaccine, and Asian participants were significantly more likely to accept a vaccine, compared to White peers. As the planning of COVID-19 vaccine rollout efforts is conceptualized and designed, these data may inform equitable implementation strategies and prevent worsening health inequities among SGM populations.</p>

DOI10.3390/vaccines9030204
Alternate JournalVaccines (Basel)
PubMed ID33804530
PubMed Central IDPMC7999863
Grant ListP30 AI060354 / AI / NIAID NIH HHS / United States
U19HD089881 / / National Institutes of Health Adolescent Medicine Trials Network for HIV/AIDS Interventions and the University of North Carolina/Emory Center for Innovative Technology /
T32HS0226116 / / Agency for Healthcare Research and Quality /